Cancer Research The Future of Cancer Research: Science and Patient Impact  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 43, 3539-3543, August 1, 1983]
© 1983 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mulcahy, R. T.
Right arrow Articles by Dembs, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mulcahy, R. T.
Right arrow Articles by Dembs, N.

Time-Dose Relationships for Simultaneous Misonidazole and 1,3-Bis(2-chloroethyl)-1-nitrosourea Exposures in Vitro1

R. Timothy Mulcahy2 and Nancy Dembs

Department of Pathology and the University of Rochester Cancer Center, University of Rochester School of Medicine, Rochester, New York 14642

The effect of incubating KHT-iv tumor cells with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) alone or in simultaneous combination with the radiation sensitizer misonidazole (MISO) was determined for aerobic and hypoxic incubations. Relative to aerobic exposures, the cytotoxicity of BCNU was significantly enhanced when KHT-iv cells were exposed under hypoxic conditions for 1 hr. This effect was apparently related to a trypsin effect and was absent in experiments with cells trypsinized immediately prior to treatment. In contrast to 1-hr exposures, treatment for 4 hr to the same total BCNU exposure doses resulted in equivalent cell killing under aerobic and hypoxic conditions.

The addition of 3 mM MISO to the 1-hr treatment protocol did not significantly modify the toxicity of BCNU toward aerobic or hypoxic cultures of KHT-iv cells. However, the cell-killing efficiency of BCNU during a 4-hr hypoxic exposure was significantly enhanced by the addition of MISO doses as small as 0.5 mM. Addition of sensitizer did not modify the 4-hr aerobic toxicity of BCNU. The decay of BCNU was not significantly altered by MISO or by low oxygen tensions, effectively eliminating the role of altered pharmacokinetics in this example of in vitro chemosensitization. These results suggest that prolonged exposure times and hypoxia are prerequisites for the expression of chemosensitization when MISO is combined simultaneously with certain chemotherapeutic agents in vitro. By comparison to the doses of MISO used in preincubation experiments, it was possible to produce enhanced cytotoxicity by relatively small MISO doses.

1 This work was supported by a grant from the United Cancer Council and NIH Grants CA32374 and CA20329.

2 To whom requests for reprints should be addressed.

Received 1/ 3/83. Accepted 4/29/83.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1983 by the American Association for Cancer Research.